Doing Well by Doing Good: Life Science in the 21st Century
Bill Greene, Director, MPM Capital
At the dawn of the biotech era, investing in “new biology” was all about the tools of science and the promise of turning genes intro drugs. Now, more than 30 years later, there are over 300 biotech companies and several blockbuster drugs have been developed from their efforts. But what has made a real difference in these achievements? Venture capitalist and former Genentech scientist Greene will discuss what bioscience is doing to address our personal and global needs.
MLF: HEALTH & MEDICINE/SCIENCE & TECHNOLOGYLocation: SF Club OfficeTime: 5:30 networking reception, 6 p.m. programCost: $8 members, $15 non-membersProgram Organizer: Bill Grant